T2D-PT201

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameT2D-PT201
Drug Alias NameT2D-PT201T-2-D-PT-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPorosome Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPorosome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A